Chandra Bhagat

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE07QQ01016
  • NSEID:
  • BSEID: 542934
INR
45.00
0.00 (0.00%)
BSENSE

Dec 18

BSE+NSE Vol: 1000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -60.83% vs 84.98% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 79.78% vs -312.04% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 40.41% vs -36.56% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -43.95% vs 69.02% in Mar 2024

Compare Profit and Loss Results of Chandra Bhagat
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
86.00
120.00
-34.00
-28.33%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
86.00
120.00
-34.00
-28.33%
Expenditure (Ex Depriciation)
Stock Adjustments
7.00
-4.00
11.00
275.00%
Raw Materials Consumed
65.00
114.00
-49.00
-42.98%
Power & Fuel Cost
0.00
1.00
-1.00
-100.00%
Employee Cost
2.00
3.00
-1.00
-33.33%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
0.00
5.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
88.00
116.00
-28.00
-24.14%
Operating Profit (PBDIT) excl Other Income
-1.00
4.00
-5.00
-125.00%
Other Income
5.00
2.00
3.00
150.00%
Operating Profit (PBDIT)
4.00
6.00
-2.00
-33.33%
Interest
1.00
2.00
-1.00
-50.00%
Profit before Depriciation and Tax
2.00
3.00
-1.00
-33.33%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
1.00
2.00
-1.00
-50.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1.00
2.00
-1.00
-50.00%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
0.00
2.00
-2.00
-100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
8.00
7.00
1.00
14.29%
Profit Available for appropriations
8.00
9.00
-1.00
-11.11%
Appropriations
8.00
9.00
-1.00
-11.11%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.14
2.57
-1.43
-55.64%
Profit And Loss - Net Sales
Net Sales 86.72 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -60.83% vs 84.98% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.42 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 79.78% vs -312.04% in Mar 2024

Profit And Loss - Interest
Interest 1.95 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 40.41% vs -36.56% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 0.86 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -43.95% vs 69.02% in Mar 2024